Getting help can be a challenge when you have idiopathic hypersomnia. The condition isn’t well-understood, and it’s hard to find a treatment that really works. To take control of your care, you need ...

Michael Thorpy, MD, professor of neurology, Albert Einstein College of Medicine explores the current treatment landscape of idiopathic hypersomnia and the associated challenges with approving new ...

Regulatory mechanisms mediated by non-coding RNAs provide valuable insights into the pathogenesis of idiopathic pulmonary fibrosis.

Topline results from the phase 3 REVITALYZ study show sodium oxybate extended release improves daytime sleepiness in idiopathic hypersomnia.

Many people with idiopathic hypersomnia (IH) experience depressive symptoms. The cause of IH is unknown, so it’s hard to say whether one condition causes the other. Many people with idiopathic ...

Spherix Global Insights highlights rising enthusiasm for Priovant’s TYK2/JAK1 inhibitor alongside continued dissatisfaction ...

Second randomized trial shows slowing of lung function loss ...

The IPF market is expanding due to rising demand for effective treatments, driven by aging populations and medical innovations. Key players like Boehringer Ingelheim and Roche dominate with ...